Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9834566
APP PUB NO 20170057977A1
SERIAL NO

15119431

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIIV HEALTHCARE UK (NO 5) LIMITED980 GREAT WEST ROAD BRENTFORD MIDDLESEX TW89GS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kadow, John F Wallingford, US 185 1556
Naidu, B Narasimhulu Wallingford, US 77 382
Patel, Manoj Wallingford, US 51 188
Peese, Kevin Wallingford, US 16 29
Wang, Tao Wallingford, US 1447 9693
Yin, Zhiwei Wallingford, US 73 378
Zhang, Zhongxing Wallingford, US 126 860

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00